The RET gene is observed in 1-2% of all NSCLC patients with chromosomal rearrangements and is involved in various fusion partners such as KIF5B, TRIM33, CCDC6, and NCOA4 (103, 104). This evidence concerns the gene KIF5B and non-small cell lung carcinoma.